France Down Syndrome Market to 2032
Overview
The France Down Syndrome Market is expected to reach a 160.48 USD Million by 2032 and is projected to grow at a CAGR of 23.30% from 2025 to 2032.
Revenue, 2024 (USD Million)
53.83
Forecast, 2032 (USD Million)
160.48
CAGR, 2024 - 2032
23.30%
Report Coverage
France
France Down Syndrome Market 2018-2032 USD Million
France Down Syndrome Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 53.83 USD Million
- Projected Market Size (2032): 160.48 USD Million
- CAGR (2025-2032): 23.30%
Key Findings of France Down Syndrome Market
- The France Down Syndrome Market was valued at 53.83 USD Million in 2024.
- The France Down Syndrome Market is likely to grow at a CAGR of 23.30% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Trisomy 21 in Disease Type Segment accounted for the largest share of the market with a revenue of 50.23 USD Million
- The fastest growing segment Therapy Centers in End User Segment grew Fastest with a CAGR of 27.39% during the forecast period from 2024 to 2032.
France Down Syndrome Market Scope
France Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
France Down Syndrome Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 53.83 USD Million |
| Market Value in 2032 | 160.48 USD Million |
| CAGR (2025-2032) | 23.30% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment, End User, Distribution Channel, Disease Type |
Regional Insights:
-
Leading Market (2024-2032): France, leading in terms of revenue 53.83 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 53.83 USD Million in 2024.
Segments and Scope
-
France Down Syndrome Market to 2032, By Treatment
- Diagnosis is the largest segment in France Down Syndrome Market to 2032 with a revenue of 47.89 USD Million in the year 2024.
- Therapy is the Fastest growing segment in France Down Syndrome Market to 2032 with a Growth rate of 22.99 % in forecast period 2025-2032.
-
France Down Syndrome Market to 2032, By End User
- Hospital is the largest segment in France Down Syndrome Market to 2032 with a revenue of 33.33 USD Million in the year 2024.
- Therapy Centers is the Fastest growing segment in France Down Syndrome Market to 2032 with a Growth rate of 23.14 % in forecast period 2025-2032.
-
France Down Syndrome Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in France Down Syndrome Market to 2032 with a revenue of 40.42 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in France Down Syndrome Market to 2032 with a Growth rate of 24.77 % in forecast period 2025-2032.
-
France Down Syndrome Market to 2032, By Disease Type
- Trisomy 21 is the largest segment in France Down Syndrome Market to 2032 with a revenue of 50.23 USD Million in the year 2024.
- Trisomy 21 is the Fastest growing segment in France Down Syndrome Market to 2032 with a Growth rate of 23.59 % in forecast period 2025-2032.
France Down Syndrome Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
France Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Million
France Down Syndrome Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The France Down Syndrome Market is segmented based on Segmentation Treatment, End User, Distribution Channel, Disease Type.
France Down Syndrome Market was valued at USD 53.83(Revenue in USD Million) in 2020.
France Down Syndrome Market is projected to grow at a CAGR of 23.30% during the forecast period of 2024 to 2032.
The Trisomy 21 segment is expected to dominate the France Down Syndrome Market, holding a largest market share of 50.23 USD Million in 2024
France Down Syndrome Market Scope
France Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
Frequently Asked Questions
The France Down Syndrome Market is segmented based on Segmentation Treatment, End User, Distribution Channel, Disease Type.
France Down Syndrome Market was valued at USD 53.83(Revenue in USD Million) in 2020.
France Down Syndrome Market is projected to grow at a CAGR of 23.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Down Syndrome Market for final year is USD 160.48 (USD Million).
France Down Syndrome Market Company Profiling
Frequently Asked Questions
The France Down Syndrome Market is segmented based on Segmentation Treatment, End User, Distribution Channel, Disease Type.
France Down Syndrome Market was valued at USD 53.83(Revenue in USD Million) in 2020.
France Down Syndrome Market is projected to grow at a CAGR of 23.30% during the forecast period of 2024 to 2032.
The estimated market value of the France Down Syndrome Market for final year is USD 160.48 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.